All News

This month's OTC product news features Zinc Complex supplements, Similac 360 Total Care, and Flora Biome Live Probiotic.

Investigators used SC144, an FDA-approved molecule, to find a new pathway for a generation of nonhormonal contraceptives.

Study shows that high infliximab trough levels linked to a low risk of relapse after switching to subcutaneous infliximab in patients with inflammatory bowel disease.

Imodium provides relief of acute nonspecific diarrhea and chronic diarrhea associated with inflammatory bowel disease.

Maribavir (Livtencity) is indicated for the treatment of adults and pediatric patients with post-transplant cytomegalovirus infection.

Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown University and a urologic surgeon, discusses some social and cultural aspects that may contribute to hypoactive sexual desire disorder going untreated in women.

During the period in which Omicron was the dominant variant, the researchers found that fewer patients died while hospitalized compared with those admitted when the Delta variant was dominant.

Alec Smith Insulin Affordability Act provides citizens with a long-term solution to diabetes expenditures.

Experts discuss women's health and health care during the COVID-19 pandemic as part of the Pharmacy Times® Pharmacy Focus webcast series.

At the Day 3 primary endpoint, zuranolone 50 mg co-initiated with a standard of care antidepressant showed a statistically significant reduction in depressive symptoms.

Jeff Trinkl, MD, director of clinical informatics at Epic, and Caleb Cox, data scientist at Epic, explain that only about 1.8% of patients contracted COVID-19 during a hospital stay at the highest peak of cases in December 2020.

Hospital-onset clostridium difficile infections frequently occur because of both patient and environmental risk factors.

The treatment for hypertrophic cardiomyopathy met its primary endpoint at week 6 in the phase 3 VALOR-HCM trial, the pharmaceutical company says.

Beano helps prevent flatulence, abdominal bloating, and stomach pain.

Finerenone (Kerendia) is indicated to reduce the risk of sustained eGFR decline, end stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease.

The application is based on data showing that lisocabtagene provides clinically meaningful and statistically significant improvement for those with relapsed or refractory large B-cell lymphoma.

Sebastian Denison, RPh, BScPharm, said new developments are constantly being published for the use of low-dose naltrexone in patients with inflammatory and autoimmune diseases.

Although marketing may seem intimidating, pharmacy owners should jump in and discover what works best for their pharmacy.

In the report published by The Lancet, the group provides a brief history of drug use and addiction, describes the opioid landscape, and includes 7 recommendations.

Tyler Woods, PharmD, pharmacy district manager with VMC Buying Group, discussed how partnering together can help independent pharmacies obtain drugs at a lower cost.

Jen Diehl, CPA, discussed some common financial concerns for independent pharmacies and where she sees the landscape heading in the future.

In the fifth episode of Coffee With Suzy, Suzanne Soliman, PharmD, BCMAS, sat down with Joanna Lewis, PharmD, MBA and Christina Madison, PharmD, FCCP, AAHIVP.

Sachin Nagrani, MD, the medical director of Heal, discusses his predictions for the future as we continue to fight the COVID-19 pandemic.

Pharmacists can use these toolkits to answer questions and make clinical designs for medication therapy management services.

Pharmacy technicians are continuing to prove their worth as pharmacies shift their focus to the future, according to Jessica Langley-Loep, executive director of education and advocacy at the National Healthcareer Association.

Although pharmacotherapy is considered for the treatment of insomnia, medication should not be the sole treatment for individuals diagnosed with insomnia.

Tom Wheelwright, CPA, founder and CEO of WealthAbility, discussed his perspective on taxes and how pharmacies can use them to their advantage.

Although prevention decreased with time, a third booster dose was still highly effective at preventing severe illness with COVID-19.

Data from the CALIBRATE and CAPELLA trials show high rates of virologic suppression with the capsid inhibitor.